{
    "clinical_study": {
        "@rank": "126206", 
        "arm_group": [
            {
                "arm_group_label": "drug use counselling", 
                "arm_group_type": "Experimental", 
                "description": "Pharmacist conducting drug reconciliation, medication reviews and drug use counselling during hospitalisation. Follow up telephone calls 1 week, 1 month, 2 months and three months after discharge from hospital"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "The patients in the control group receive no intervention just treatment and follow up according to national standards"
            }
        ], 
        "brief_summary": {
            "textblock": "Use of drugs is an important factor in secondary prophylaxis after transient ischemic attack\n      (TIA), but studies show that adherence to the prescribed drugs is often poor. This\n      randomised controlled trial aims to investigate whether a systematic follow up of drug\n      treatment using medication reconciliation, medication reviews and patient counselling by\n      clinical pharmacists, improves adherence and/or decreases cardiovascular events the first\n      three months and the first year after TIA. Patient satisfaction will also be compared\n      between the two groups."
        }, 
        "brief_title": "Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ischemic Attack, Transient", 
            "Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Ischemic Attack, Transient", 
                "Ischemia", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Probable or possible transient ischemic attack\n\n          -  Residing in Central Norway\n\n          -  Examined within 2 weeks after the onset of symptoms\n\n          -  Modified Rankin Scale 3 or less and living at home\n\n          -  enrolled in the MIDNOR-TIA study NCT02038725\n\n          -  Informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02089074", 
            "org_study_id": "2012/1224a"
        }, 
        "intervention": {
            "arm_group_label": "drug use counselling", 
            "intervention_name": "Drug use counselling", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Secondary Prevention", 
            "Pharmacists", 
            "Directive Counseling", 
            "Medication Adherence", 
            "Patient Compliance"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.ntnu.no/inm/midnor-tia"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Kristiansund", 
                        "country": "Norway"
                    }, 
                    "name": "Kristiansund Sykehus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Levanger", 
                        "country": "Norway"
                    }, 
                    "name": "Levanger Sykehus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Molde", 
                        "country": "Norway"
                    }, 
                    "name": "Molde Sykehus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Namsos", 
                        "country": "Norway"
                    }, 
                    "name": "Namsos Sykehus"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fredrik.ildstad@ntnu.no", 
                    "last_name": "Fredrik Ildstad"
                }, 
                "facility": {
                    "address": {
                        "city": "Trondheim", 
                        "country": "Norway"
                    }, 
                    "name": "St Olavs Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "\u00c5lesund", 
                        "country": "Norway"
                    }, 
                    "name": "\u00c5lesund Sykehus"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack: Adherence and Cardiovascular Events in the First Three Months", 
        "overall_contact": {
            "email": "janne.k.sund@ntnu.no", 
            "last_name": "Janne K Sund, PhD student"
        }, 
        "overall_contact_backup": {
            "email": "bent.indredavik@ntnu.no", 
            "last_name": "Bent Indredavik, PhD, Prof"
        }, 
        "overall_official": {
            "affiliation": "Norwegian University of Science and Technology", 
            "last_name": "Bent Indredavik, PhD, Prof", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "self reporting of adherence", 
            "measure": "adherence to drug treatment in secondary prevention after TIA", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02089074"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "self reporting of adherence", 
                "measure": "adherence to drug treatment in secondary prevention after TIA", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Persistence measured by control of filled prescriptions", 
                "measure": "Persistence", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Measured by using data from national health registries", 
                "measure": "Incidence of stroke and cardiovascular events and deaths", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "measured by modified Rankin Scale and indirectly by level of care", 
                "measure": "degree of disability or dependence in the daily activities", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Measured by using data from the Norwegian Stroke Registry", 
                "measure": "patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Persistence measured by control of filled prescriptions", 
                "measure": "Persistence", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Measured by using data from national health registries", 
                "measure": "Incidence of stroke and cardiovascular events and deaths", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "measured by modified Rankin Scale and indirectly by level of care", 
                "measure": "degree of disability or dependence in the daily activities", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Measured by using data from the Norwegian Stroke Registry", 
                "measure": "patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Norwegian University of Science and Technology", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "St. Olavs Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Helse Midt-Norge", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Sykehusapotekene i Midt Norge", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Norwegian University of Science and Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}